- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06851130
Avaliando o aumento imediato da ferritina sérica após doses orais de ferro: um estudo experimental em mulheres deficientes em ferro (INFER 2)
Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Canton of Zurich
-
Zurich, Canton of Zurich, Suíça, 8092
- Laboratory of Nutrition and Metabolic Epigenetics
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Low iron stores (SF levels < 30 µg/L),
- no anemia (Hb > 120 g/L)
- no inflammation (CRP < 5 mg/L)
- 18 to 45 years old.
- Body weight <70 kg
- Normal body Mass Index (18.5-26.5 kg/m2)
Exclusion Criteria:
- Any chronic or acute disease
- Consumption of mineral and vitamin supplements since screening and over the study period
- Blood transfusion, blood donation or significant blood loss over the past 4 months,
- Pregnant or breastfeeding,
- Continuous/long-term use of medication during the whole studies (except for contraceptives)
- Therapeutic iron infusion over the past 6 months,
- Known hypersensitivity or allergy to iron supplements,
- Intention to become pregnant over the course of the study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: 80 mg
Daily dose of 80 mg of iron for 1 month, with a 7-day break, then again for another month (2 months total). |
1 tablet per day |
|
Experimental: 160
Daily dose of 160 mg of iron for 1 month, with a 7-day break, then again for another month (2 months total). |
2 tablets per day |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Serum ferritin
Prazo: Study day 31
|
Serum ferritin concentration |
Study day 31
|
|
Serum ferritin
Prazo: Study day 37
|
Serum ferritin concentration |
Study day 37
|
|
Serum ferritin
Prazo: Study day 68
|
Serum ferritin concentration |
Study day 68
|
|
Serum ferritin
Prazo: Study day 74
|
Serum ferritin concentration |
Study day 74
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 1
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 1
|
|
Serum ferritin
Prazo: Study day 30
|
Serum ferritin concentration |
Study day 30
|
|
Serum ferritin
Prazo: Study day 67
|
Serum ferritin concentration |
Study day 67
|
|
Serum ferritin
Prazo: Study day 20
|
Serum ferritin concentration |
Study day 20
|
|
Serum ferritin
Prazo: Study day 36
|
Serum ferritin concentration |
Study day 36
|
|
Serum ferritin
Prazo: Study day 57
|
Serum ferritin concentration |
Study day 57
|
|
Serum ferritin
Prazo: Study day 72
|
Serum ferritin concentration |
Study day 72
|
|
Serum ferritin
Prazo: Study day 71
|
Serum ferritin concentration |
Study day 71
|
|
Serum ferritin
Prazo: Study day 70
|
Serum ferritin concentration |
Study day 70
|
|
Serum ferritin
Prazo: Study day 69
|
Serum ferritin concentration |
Study day 69
|
|
Serum ferritin
Prazo: Study day 73
|
Serum ferritin concentration |
Study day 73
|
|
Serum ferritin
Prazo: Study day 47
|
Serum ferritin concentration |
Study day 47
|
|
Serum ferritin
Prazo: Study day 35
|
Serum ferritin concentration |
Study day 35
|
|
Serum ferritin
Prazo: Study day 34
|
Serum ferritin concentration |
Study day 34
|
|
Serum ferritin
Prazo: Study day 33
|
Serum ferritin concentration |
Study day 33
|
|
Serum ferritin
Prazo: Study day 32
|
Serum ferritin concentration |
Study day 32
|
|
Serum ferritin
Prazo: Study day 10
|
Serum ferritin concentration |
Study day 10
|
|
Serum ferritin
Prazo: Study day 6
|
Serum ferritin concentration |
Study day 6
|
|
Serum ferritin
Prazo: Study day 3
|
Serum ferritin concentration |
Study day 3
|
|
Serum Ferritin
Prazo: Study Day 1
|
Serum Ferritin concentration |
Study Day 1
|
|
Hemoglobin
Prazo: Study day 1
|
Hemoglobin concentration |
Study day 1
|
|
C-reactive protein
Prazo: Study day 1
|
C-reactive protein concentration in serum |
Study day 1
|
|
C-reactive protein
Prazo: Study day 3
|
C-reactive protein concentration in serum |
Study day 3
|
|
C-reactive protein
Prazo: Study day 6
|
C-reactive protein concentration in serum |
Study day 6
|
|
C-reactive protein
Prazo: Study day 10
|
C-reactive protein concentration in serum |
Study day 10
|
|
C-reactive protein
Prazo: Study day 20
|
C-reactive protein concentration in serum |
Study day 20
|
|
C-reactive protein
Prazo: Study day 30
|
C-reactive protein concentration in serum |
Study day 30
|
|
C-reactive protein
Prazo: Study day 31
|
C-reactive protein concentration in serum |
Study day 31
|
|
C-reactive protein
Prazo: Study day 32
|
C-reactive protein concentration in serum |
Study day 32
|
|
C-reactive protein
Prazo: Study day 33
|
C-reactive protein concentration in serum |
Study day 33
|
|
C-reactive protein
Prazo: Study day 34
|
C-reactive protein concentration in serum |
Study day 34
|
|
C-reactive protein
Prazo: Study day 35
|
C-reactive protein concentration in serum |
Study day 35
|
|
C-reactive protein
Prazo: Study day 36
|
C-reactive protein concentration in serum |
Study day 36
|
|
C-reactive protein
Prazo: Study day 37
|
C-reactive protein concentration in serum |
Study day 37
|
|
C-reactive protein
Prazo: Study day 47
|
C-reactive protein concentration in serum |
Study day 47
|
|
C-reactive protein
Prazo: Study day 57
|
C-reactive protein concentration in serum |
Study day 57
|
|
C-reactive protein
Prazo: Study day 67
|
C-reactive protein concentration in serum |
Study day 67
|
|
C-reactive protein
Prazo: Study day 68
|
C-reactive protein concentration in serum |
Study day 68
|
|
C-reactive protein
Prazo: Study day 69
|
C-reactive protein concentration in serum |
Study day 69
|
|
C-reactive protein
Prazo: Study day 70
|
C-reactive protein concentration in serum |
Study day 70
|
|
C-reactive protein
Prazo: Study day 71
|
C-reactive protein concentration in serum |
Study day 71
|
|
C-reactive protein
Prazo: Study day 72
|
C-reactive protein concentration in serum |
Study day 72
|
|
C-reactive protein
Prazo: Study day 73
|
C-reactive protein concentration in serum |
Study day 73
|
|
C-reactive protein
Prazo: Study day 74
|
C-reactive protein concentration in serum |
Study day 74
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 3
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 3
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 6
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 6
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 10
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 10
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 20
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 20
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 30
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 30
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 31
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 31
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 32
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 32
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 33
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 33
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 34
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 34
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 35
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 35
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 36
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 36
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 37
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 37
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 47
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 47
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 57
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 57
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 67
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 67
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 68
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 68
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 69
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 69
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 70
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 70
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 71
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 71
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 72
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 72
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 73
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 73
|
|
alpha(1)-acid-glycoprotein
Prazo: Study day 74
|
alpha(1)-acid-glycoprotein concentration in serum |
Study day 74
|
|
Hemoglobin
Prazo: Study day 10
|
Hemoglobin concentration |
Study day 10
|
|
Hemoglobin
Prazo: Study day 20
|
Hemoglobin concentration |
Study day 20
|
|
Hemoglobin
Prazo: Study day 30
|
Hemoglobin concentration |
Study day 30
|
|
Hemoglobin
Prazo: Study day 37
|
Hemoglobin concentration |
Study day 37
|
|
Hemoglobin
Prazo: Study day 47
|
Hemoglobin concentration |
Study day 47
|
|
Hemoglobin
Prazo: Study day 57
|
Hemoglobin concentration |
Study day 57
|
|
Hemoglobin
Prazo: Study day 67
|
Hemoglobin concentration |
Study day 67
|
|
Hemoglobin
Prazo: Study day 74
|
Hemoglobin concentration |
Study day 74
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- INFER Study 2
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .